Wei Wang

Executive Officer, Director at IVIEW Therapeutics.

Cranbury, NJ
IVIEW Therapeutics

Raised on IVIEW Therapeutics filings

$9.2M

of $15M offered across 2 Form D filings

Form D filings: 2
Teammates: 6
Last filing: Jun 10, 2025

Company

IVIEW Therapeutics

Biotech · Cranbury, NJ

Eyelid wipe drug for dry eye disease

Eyelid wipe drug for dry eye disease

Investors: 4
Still open: $5.8M

Investors: 4
Sector: Biotech
HQ: Cranbury, NJ

IVIEW Therapeutics filings

IVIEW Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Jun 10, 2025	Equity	$9.2M/ $15M	Form D/A
Feb 24, 2025	Equity	$7.7M/ $15M	Form D/A

EquityFiled Jun 10, 2025Form D/A
$9.2M/ $15M
EquityFiled Feb 24, 2025Form D/A
$7.7M/ $15M

Works with

Also named on IVIEW Therapeutics filings

Bo LiangChief Executive Officer, Form D signerForm D signer Xiaolu SunDirector Bin HeDirector Houman HemmatiExecutive Officer, Director Jingjie LiDirector Qi ZhuDirector